These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8341218)

  • 1. N-myc oncogene and urinary catecholamines in children with neuroblastoma.
    Barontini M; Gutiérrez MI; Levin G; Mur N; Diez B
    Med Pediatr Oncol; 1993; 21(7):499-504. PubMed ID: 8341218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
    Izbicki T; Bozek J; Perek D; Wozniak W
    J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
    Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal activity may predict aggressive behavior in neuroblastoma.
    Zambrano E; Reyes-Múgica M
    Pediatr Dev Pathol; 2002; 5(2):190-9. PubMed ID: 11910515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
    Zhang H; He X; Miao Q; Li L; Song J; Jiang X
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
    Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
    Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of N-myc gene and increase of urinary VMA and HVA in patients with neuroblastic tumors.
    Akimaru K; Shoji T; Fukunaga Y; Yamamoto M; Ishizaki R; Nomura N
    Nihon Ika Daigaku Zasshi; 1994 Apr; 61(2):148-53. PubMed ID: 8195324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.
    Tonini GP; Boni L; Pession A; Rogers D; Iolascon A; Basso G; Cordero di Montezemolo L; Casale F; Pession A; Perri P; Mazzocco K; Scaruffi P; Lo Cunsolo C; Marchese N; Milanaccio C; Conte M; Bruzzi P; De Bernardi B
    J Clin Oncol; 1997 Jan; 15(1):85-93. PubMed ID: 8996128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
    Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
    Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [N-myc gene copies in children with neuroblastoma and its clinical significance].
    Ma XL; Gong LP; Zhou CJ; Zhang DW; Jin M; Wang HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1447-51. PubMed ID: 23257451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of N-myc amplification with neuroblastoma: the Australian and New Zealand experience.
    Telford DJ; Kavallaris M; White L; Norris MD; Brian MJ; Stewart BW
    J Paediatr Child Health; 1992 Feb; 28(1):58-63. PubMed ID: 1554517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-myc gene amplification in neuroblastoma: a clinical approach using ultrasound guided cutting needle biopsies collected at diagnosis.
    Hedborg F; Lindgren PG; Johansson I; Kogner P; Samuelsson BO; Bekassy AN; Olsen L; Kreuger A; Påhlman S
    Med Pediatr Oncol; 1992; 20(4):292-300. PubMed ID: 1608350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
    Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
    Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma).
    Fabbretti G; Valenti C; Loda M; Brisigotti M; Cozzutto C; Tonini GP; Callea F
    Hum Pathol; 1993 Mar; 24(3):294-7. PubMed ID: 8454274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.